Giant Biogene Holding Co., Ltd. (2367.HK) HKSE
Currency In HKD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 31.62B |
| Enterprise Value | 25.32B |
| P/E Ratio | 11.66 |
| PEG Ratio | -0.97 |
| Price/Sales Ratio | 4.11 |
| Price/Book Ratio | 2.3 |
| Enterprise/Revenue | 2.96 |
| Enterprise/EBITDA | 7.45 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | December 31, 2025 |
Profitability
| Profit Margin | 0.35 |
| Operating Margin | 0.38 |
AD
Management Effectiveness
| Return On Assets | 0.18 |
| Return On Equity | 0.2 |
Income Statement
| Revenue | 5.52B |
| Revenue/Share | 5.15 |
| Gross Profit | 4.43B |
| EBITDA | 2.19B |
| Net Income | 1.91B |
| Diluted EPS | 1.81 |
Balance Sheet
| Total Cash | 8.29B |
| Total Cash/Share | 7.75 |
| Total Debt | 9.69M |
| Total Debt/Equity | 0 |
| Current Ratio | 11.27 |
| Book Value Per Share | 9.27 |
Price History
| 52-Week Change | -51.76 |
| 52-Week High | 65.7 |
| 52-Week Low | 24.7 |
| Moving Average 50 Days | 28.9 |
| Moving Average 200 Days | 36.25 |
Statistics
| Average Volume | 5.39M |
| Shares Outstanding | 1.06B |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 2.33 |
| Trailing Annual Dividend Yield | 10.91 |
| Payout Ratio | 0.66 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
